celecoxib has been researched along with Hypertrophy in 2 studies
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "With treatment with celecoxib, PGE(2) levels, the gastric mucosal thickness, and the number of total gastric cells per gastric gland of ACT-GAS mice were significantly decreased." | 1.33 | Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice. ( Chiba, T; Fukui, H; Kanda, N; Kawada, M; Konda, Y; Nakajima, T; Sawabu, T; Seno, H; Takeuchi, T; Uenoyoma, Y, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H | 1 |
| Wang, Y | 1 |
| Cao, Y | 1 |
| Wu, B | 1 |
| Li, Y | 1 |
| Fan, L | 1 |
| Tan, Z | 1 |
| Jiang, Y | 1 |
| Tang, J | 1 |
| Hu, J | 1 |
| Shi, X | 1 |
| Kanda, N | 1 |
| Seno, H | 1 |
| Kawada, M | 1 |
| Sawabu, T | 1 |
| Uenoyoma, Y | 1 |
| Nakajima, T | 1 |
| Konda, Y | 1 |
| Fukui, H | 1 |
| Takeuchi, T | 1 |
| Chiba, T | 1 |
2 other studies available for celecoxib and Hypertrophy
| Article | Year |
|---|---|
Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis.
Topics: Biomarkers; Biopsy; Celecoxib; DNA Mutational Analysis; Gastric Mucosa; Humans; Hypertrophy; Immunoh | 2017 |
Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice.
Topics: Animals; Apoptosis; Celecoxib; Cyclooxygenase 2; Dinoprostone; Gastric Mucosa; Gastrins; Gene Expres | 2006 |